Use of disease risk scores in pharmacoepidemiologic studies
- 1 February 2009
- journal article
- review article
- Published by SAGE Publications in Statistical Methods in Medical Research
- Vol. 18 (1) , 67-80
- https://doi.org/10.1177/0962280208092347
Abstract
Automated databases are increasingly used in pharmacoepidemiologic studies. These databases include records of prescribed medications and encounters with medical care providers from which one can construct very detailed surrogate measures for both drug exposure and covariates that are potential confounders. Often it is possible to track day-by-day changes in these variables. However, while this information is often critical for study success, its volume can pose challenges for statistical analysis. One common approach is the use of propensity scores. An alternative approach is to construct a disease risk score. This is analogous to the propensity score in that it calculates a summary measure from the covariates. However, the disease risk score estimates the probability or rate of disease occurrence conditional on being unexposed. The association between exposure and disease is then estimated adjusting for the disease risk score in place of the individual covariates. This review describes the use of disease risk scores in pharmacoepidemiologic studies, and includes a brief discussion of their history, a more detailed description of their construction and use, a summary of simulation studies comparing their performance vis-á-vis traditional models, a comparison of their utility with that of propensity scores, and some further topics for future research.Keywords
This publication has 25 references indexed in Scilit:
- Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control studyThe Lancet, 2005
- Oral Erythromycin and the Risk of Sudden Death from Cardiac CausesNew England Journal of Medicine, 2004
- Cyclic antidepressants and the risk of sudden cardiac deathClinical Pharmacology & Therapeutics, 2004
- COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart diseaseThe Lancet, 2002
- Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort studyThe Lancet, 2002
- Bootstrap investigation of the stability of a cox regression modelStatistics in Medicine, 1989
- Performance of tests of significance based on stratification by a multivariate confounder score or by a propensity scoreJournal of Clinical Epidemiology, 1989
- The central role of the propensity score in observational studies for causal effectsBiometrika, 1983
- Some insights into Miettinen's multivariate confounder score approach to case-control study analysis.Journal of Epidemiology and Community Health, 1979
- STRATIFICATION BY A MULTIVARIATE CONFOUNDER SCOREAmerican Journal of Epidemiology, 1976